Found 12 matching trials
The Efficacy of Neoadjuvant Chemoradiotherapy in Comparison With Neoadjuvant Chemotherapy in Patients With Resectable Squamous Cell Esophageal Cancer
PHASE3The purpose of this study is to evaluate the safety, feasibility and outcom...
Location
N.N. Blokhin National Medical Research Center of Oncology
Pembrolizumab Plus Neoadjuvant Chemotherapy vs. Neoadjuvant Chemoradiotherapy for Locally Advanced ESCC (KEYSTONE-002)
PHASE3The purpose of this study is to evaluate the efficacy and safety of pembrol...
Location
Department of minimally invasive esophageal surgery, Tianjin Medical University Cancer Institute and Hospital
Study of Docetaxel or Vinorelbine Plus Cisplatin in Neoadjuvant Chemoradiotherapy for Esophageal Cancer (NEOCRTEC308)
PHASE3The primary objective is to compare docetaxel plus cisplatin (DP) versus vi...
Location
Sun Yat-sen University Cancer Center
PD-1 Inhibitor Combined With Neoadjuvant Chemoradiotherapy Plus Surgery for Locally Advanced ESCC (NEOCRTEC2101)
PHASE3The primary objective is to compare PD-1 inhibitor combined with preoperati...
Location
Sun Yat-sen University Cancer Center
Pre-Operative Pembrolizumab + Chemoradiation in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma
PHASE2To investigate the safety and activity of preoperative pembrolizumab combin...
Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Neoadjuvant Cardonilizumab Combined With Neoadjuvant Chemoradiotherapy Can Resect Locally Advanced Esophageal Squamous Cell Carcinoma
PHASE2This is a multicenter, open-label, randomized, controlled clinical study to...
Anastomotic Leaks in Esophageal Squamous Cell Carcinoma Patients After Trimodal Therapy
N/ATo investigate the clinical factors and preoperative treatment to the futur...
Location
Sun Yat-sen University Cancer Center
Neoadjuvant Immunotherapy Plus CRT Versus Neoadjuvant CRT for Locally Advanced Resectable ESCC
PHASE2The purpose of this study was to evaluate the safety, feasibility and outco...
Location
Shanghai Zhongshan Hospital
Camrelizumab Combined With Neoadjuvant Concurrent Chemoradiotherapy for Resectable Locally Advanced ESCC(NICE-RT)
PHASE2NICE-RT study is a "safety run-in" and phase II trial evaluating the safety...
Location
Shanghai Chest Hospital
NCRT Combined With Sequential Perioperative PD-1 Inhibitor for LAESCC
NAThis study aims to examine the efficacy of the combination of neoadjuvant c...
Status
Active Not Recruiting
Location
Radiation Oncology Department, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine